Novonix (NVX) Notes Payables (2020 - 2025)

Novonix (NVX) has reported Notes Payables for 6 consecutive years, with $62.1 million the latest figure, recorded in Q4 2025.

• Quarterly Notes Payables rose 89.38% year-over-year to $62.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $62.1 million (up 89.38% YoY) and the FY2025 annual result came in at $62.1 million, up 89.38% from the prior year.
• Notes Payables retreated to $62.1 million in Q4 2025 per NVX's latest filing, from $91.2 million in the prior quarter.
• Over the last five years, Notes Payables for NVX reached as high as $91.2 million in Q2 2025 and fell as low as $195666.6 in Q2 2021.
• A 5-year average of $38.2 million and a median of $32.8 million in 2024 frame the typical range for Notes Payables.
• Annual changes were most pronounced in 2023 — Notes Payables jumped 5950.1% — and 2024, when it plunged 51.01%.
• Year by year, Notes Payables stood at $34.1 million in 2021, then tumbled by 96.95% to $1.0 million in 2022, then soared by 2642.86% to $28.6 million in 2023, then advanced by 14.78% to $32.8 million in 2024, then jumped by 89.38% to $62.1 million in 2025.
• According to Business Quant data, Notes Payables over the past three periods registered $62.1 million, $91.2 million, and $32.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.